1RG-CART

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug Name1RG-CART

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapyCell and gene therapy > Gene therapy

Mechanisms of ActionDisialoganglioside GD2 modulatorsT lymphocyte replacements

TargetsDisialoganglioside GD2

Therapy Area/IndicationsNeuroblastoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesCancer Research UK

China Registration ClassN/A

Develop Information

Active CompaniesCancer Research UK

Inactive CompaniesN/A

Active IndicationsNeuroblastoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A